Efficacy and safety of radiotherapy plus anti-PD1 versus transcatheter arterial chemoembolization plus sorafenib for advanced hepatocellular carcinoma: a real-world study

BACKGROUND: The combination of transcatheter arterial chemoembolization (TACE) plus sorafenib prolonged progression-free survival (PFS) and overall survival (OS) than sorafenib or TACE monotherapy for patients with hepatocellular carcinoma (HCC). This study assessed the efficacy and safety of radiot...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Jian-Xu, Deng, Wen-Xiang, Huang, Shi-Ting, Lin, Xiao-Feng, Long, Mei-Ying, Zhang, Jie, Su, Ting-Shi, Li, Li-Qing, Pang, Ya-Dan, Liang, Chun-Feng, Zhou, Hong-Mei, Lu, Hai-Yan, Liang, Shi-Xiong, Xiang, Bang-De
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9188229/
https://www.ncbi.nlm.nih.gov/pubmed/35690773
http://dx.doi.org/10.1186/s13014-022-02075-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9188229/
https://www.ncbi.nlm.nih.gov/pubmed/35690773
http://dx.doi.org/10.1186/s13014-022-02075-6

Ejemplares similares